ABPI outlines top priorities for Labour’s first 100 days in office

The Association of the British Pharmaceutical Industry (ABPI) has laid out a series of urgent actions it wants the newly elected Labour government to
implement within its first 100 days in office.

Among the top priorities, the ABPI has emphasised the urgent need to appoint a new Chair and Chief Executive for the Medicines and Healthcare products Regulatory
Agency (MHRA).

Additionally, the ABPI has urged the new government to launch the Life Sciences Manufacturing Capital Grants Facility without delay.

Other measures the ABPI wants Labour to prioritise include:

Rapidly passing outstanding UK clinical trials legislation to enhance the UK’s attractiveness for inward investment, including into research within the NHS.
Increasing commercial flexibility in the NHS England Commercial Framework for New Medicines to remove barriers for companies to launch new medicines and indications
so that NHS patients can access the latest innovative medicines.